- Home
- RNTX vs ONEG Comparison
RNTX vs ONEG Comparison
Compare RNTX & ONEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNTX
- ONEG
- Stock Information
- Founded
- RNTX 2001
- ONEG 2021
- Country
- RNTX United States
- ONEG Hong Kong
- Employees
- RNTX N/A
- ONEG N/A
- Industry
- RNTX Biotechnology: Pharmaceutical Preparations
- ONEG Homebuilding
- Sector
- RNTX Health Care
- ONEG Consumer Discretionary
- Exchange
- RNTX Nasdaq
- ONEG Nasdaq
- Market Cap
- RNTX 40.3M
- ONEG 43.3M
- IPO Year
- RNTX N/A
- ONEG 2024
- Fundamental
- Price
- RNTX $1.56
- ONEG $5.02
- Analyst Decision
- RNTX
- ONEG
- Analyst Count
- RNTX 0
- ONEG 0
- Target Price
- RNTX N/A
- ONEG N/A
- AVG Volume (30 Days)
- RNTX 33.6K
- ONEG 25.4K
- Earning Date
- RNTX 08-13-2025
- ONEG 01-01-0001
- Dividend Yield
- RNTX N/A
- ONEG N/A
- EPS Growth
- RNTX N/A
- ONEG N/A
- EPS
- RNTX N/A
- ONEG 0.12
- Revenue
- RNTX N/A
- ONEG $60,903,000.00
- Revenue This Year
- RNTX N/A
- ONEG N/A
- Revenue Next Year
- RNTX N/A
- ONEG N/A
- P/E Ratio
- RNTX N/A
- ONEG $40.06
- Revenue Growth
- RNTX N/A
- ONEG 16.46
- 52 Week Low
- RNTX $1.35
- ONEG $1.48
- 52 Week High
- RNTX $4.40
- ONEG $5.78
- Technical
- Relative Strength Index (RSI)
- RNTX N/A
- ONEG N/A
- Support Level
- RNTX N/A
- ONEG N/A
- Resistance Level
- RNTX N/A
- ONEG N/A
- Average True Range (ATR)
- RNTX 0.00
- ONEG 0.00
- MACD
- RNTX 0.00
- ONEG 0.00
- Stochastic Oscillator
- RNTX 0.00
- ONEG 0.00
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. It is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project include performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.